Form 8-K - Current report:
SEC Accession No. 0001628280-21-009437
Filing Date
2021-05-07
Accepted
2021-05-07 07:35:21
Documents
2
Period of Report
2021-05-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ocgn-20210507x8ker.htm 8-K 26605
2 EX-99.1 ocgn-20210507xex991er.htm EX-99.1 68832
  Complete submission text file 0001628280-21-009437.txt   96676
Mailing Address 5 GREAT VALLEY PARKWAY SUITE 160 MALVERN PA 19355
Business Address 5 GREAT VALLEY PARKWAY SUITE 160 MALVERN PA 19355 484-328-4698
Ocugen, Inc. (Filer) CIK: 0001372299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36751 | Film No.: 21900255
SIC: 2836 Biological Products, (No Diagnostic Substances)